Biocon Bengaluru unit pre-approval inspection by USFDA concludes with zero observations

Biocon on Monday said that pre-approval inspection of the Bengaluru facility of its arm conducted by US health regulator was concluded with zero observations.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news